Parvovirus B19 infection and bone marrow transplantation N. FrickhofenR. ArnoldN. S. Young OriginalPaper Pages: A121 - A124
Hematopoietic stem cell deficiency resulting from cytomegalovirus infection of bone marrow stroma M. J. ReddehaseL. Dreher-StumppM. Šuša OriginalPaper Pages: A125 - A127
Cytomegalovirus and marrow function B. Torok-StorbP. SimmonsD. Myerson OriginalPaper Pages: A128 - A131
Myelopoiesis in vitro is suppressed by hepatitis A virus F. W. BuschA. KunstA. Vallbracht OriginalPaper Pages: A132 - A136
Intensification of GVHD prophylaxis interferes with the effects of pretransplant herpes virus serology on the occurrence of grades II–IV acute graft-versus-host disease J. W. GratamaH. v. d. NatL. F. Verdonck OriginalPaper Pages: A137 - A139
Influence of human cytomegalovirus on immune reconstitution after bone marrow transplantation C. A. MüllerH. Einsele OriginalPaper Pages: A140 - A142
Correlation of pretransplant viral serology and complications of bone marrow transplantation O. Ringdén OriginalPaper Pages: A143 - A147
Risk factors for viral reactivation following bone marrow transplantation D. PillayA. WebsterP. D. Griffiths OriginalPaper Pages: A148 - A151
Prevention of viral infections after bone marrow transplantation U. SchulerG. Ehninger OriginalPaper Pages: A152 - A157
Prevention and treatment of CMV infection after allogeneic bone marrow transplant E. GluckmanR. TraineauI. Hirsch OriginalPaper Pages: A158 - A161
Epstein-Barr virus infection in allogeneic marrow grafting: lessons for transplant physicians and virologists J. W. GratamaM. A. P. OosterveerI. Ernberg OriginalPaper Pages: A162 - A165